altRx vs Omzo: Affordable Compounded GLP-1 Care Compared
Quick verdict: altRx vs Omzo
The primary difference between altRx and Omzo is price versus clinician framing. altRx promotes a limited offer with compounded semaglutide starting at $89/month and tirzepatide at $149/month, while Omzo lists semaglutide starting at $179 and emphasizes clinician-guided, personalized plans that may include compounded or branded prescriptions. Early verdict: choose altRx if lowest advertised price and a fully online, all-in-one kit matter most; choose Omzo if you want clinician-guided options and the possibility your provider will prescribe a branded product. This article compares altRx vs Omzo across price, clinical model, medication type, delivery and terms.
Start altRx for the advertised $89/mo
Price and value: clear divergence
Cost is the most distinctive difference between altRx vs Omzo. altRx advertises a limited offer: compounded semaglutide from $89/month and compounded tirzepatide from $149/month, with multi-month plan pricing listed (for example semaglutide drops to $85/mo on a 3-month plan). Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. altRx frames itself as the most affordable GLP-1 program and highlights all-inclusive pricing that covers medical oversight and medication. Omzo presents starting prices and emphasizes clinician-guided personalization but notes pricing, eligibility and renewal terms may change.
CTA to altRx pricing
Clinical model and oversight
altRx and Omzo both use licensed clinicians to determine treatment, but they position clinical contact differently. altRx offers 100% online medical visits and says a licensed provider will review your health evaluation and conduct telehealth consultation, which may be live video or asynchronous depending on state telehealth laws. Omzo connects users with licensed U.S. providers who review medical history and make the final determination; Omzo notes it is not a medical practice and clinical services are provided by third party networks. Both require provider review and both stress provider judgment in prescribing decisions.
Medication options and regulatory notes
Both services offer compounded semaglutide and tirzepatide in their primary programs, and both include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Omzo explicitly states providers may alternatively write prescriptions for branded medications that Omzo does not sell or ship; if a branded product is prescribed, you must fill and pay for it at your chosen pharmacy. altRx repeatedly describes its offering as compounded semaglutide and compounded tirzepatide as part of its all-inclusive plans.
Delivery, kit contents, and accessibility
altRx advertises free, discreet 2-day delivery and a complete treatment kit that includes vials, syringes, prep pads and step-by-step guidance. altRx also highlights buy now, pay later options with Affirm, Klarna and Afterpay and claims availability to residents of all 50 U.S. states with provider availability varying by state. Omzo advertises fast, discreet delivery and notes medications are prepared and shipped by state-licensed sterile compounding pharmacies; Omzo also states it associates with certified U.S. pharmacies and that product appearance may differ from website images.
Terms, cancellation and eligibility
altRx emphasizes no membership, no hidden fees and a cancel anytime approach with no commitment. altRx describes multi-month plans with lower per-month pricing and says prescriptions are filled by independently owned state-licensed compounding pharmacies in its network. Omzo cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change and recommends confirming eligibility, medication, total cost, renewal terms and state availability before enrollment. Omzo also notes that results vary and eligibility is determined by providers.
| Criteria | altRx | Omzo |
|---|---|---|
| Starting price | Semaglutide from $89/mo; Tirzepatide from $149/mo | Semaglutide starting at $179; Tirzepatide starting at $279 |
| Clinical visits | 100% online medical visits; licensed provider review; telehealth | Clinician-guided plans reviewed by licensed U.S. providers; third party networks |
| Medication type | Compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide; providers may prescribe branded meds |
| Delivery and kit | Free, discreet 2-day delivery; treatment kit with syringes and supplies | Fast, discreet delivery; produced in sterile compounding pharmacies |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Explore Omzo clinician-guided plans
How results and expectations are framed
Omzo includes anecdotal patient language on its site describing individual experiences and explicitly warns that individual results may vary and are not guaranteed. altRx focuses on price and access and does not supply public outcome claims in the captured evidence beyond care team support and clinician-guided plans. Neither provider guarantees outcomes; both note provider judgment and individualized assessment determine eligibility and prescriptions.
Check Omzo eligibility and options
Conclusion: altRx vs Omzo — which to choose
altRx vs Omzo boils down to your priorities. altRx offers the lowest advertised starting price for compounded semaglutide and tirzepatide, 100% online visits, an all-in-one kit, free 2-day delivery and cancel-anytime terms. Omzo charges higher starting prices, emphasizes clinician-guided personalized care, and clearly states providers may prescribe branded medications that you must fill separately. Both use licensed clinicians and both offer compounded options with the regulatory qualifier that compounded medications are not FDA-approved.
Choose altRx if you prioritize the lowest advertised monthly price, a fully online intake and an all-inclusive treatment kit. Choose Omzo if you want clinician-guided personalization and the possibility your provider will prescribe a branded medication you can fill at a pharmacy.